Provided by Tiger Fintech (Singapore) Pte. Ltd.

Processa Pharmaceuticals, Inc.

0.2903
-0.0173-5.62%
Pre-market: 0.29140.0011+0.38%05:15 EDT
Volume:1.31M
Turnover:396.26K
Market Cap:3.45M
PE:-0.07
High:0.3131
Open:0.3000
Low:0.2883
Close:0.3076
Loading ...

Maxim Group Reaffirms Their Hold Rating on Processa Pharmaceuticals (PCSA)

TIPRANKS
·
17 May

Processa Pharmaceuticals Inc expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
07 May

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025

GlobeNewswire
·
15 Apr

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently

Insider Monkey
·
21 Feb

BRIEF-Processa Pharmaceuticals Inc - On Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance

Reuters
·
11 Feb

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

GlobeNewswire
·
07 Feb

Favourable Signals For Processa Pharmaceuticals: Numerous Insiders Acquired Stock

Simply Wall St.
·
07 Feb

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
31 Jan

BRIEF-Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules

Reuters
·
28 Jan

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
28 Jan

Processa Pharmaceuticals Inc - Purchase Price per Share $0.615 for Institutional Investors, $0.7975 for CEO and Board

THOMSON REUTERS
·
28 Jan

Processa Pharmaceuticals Files for Public Offering of up to 9.4 Mln Shares of Common Stock and Accompanying Common Warrants

THOMSON REUTERS
·
16 Jan

Processa Pharmaceuticals files to sell common stock, no amount given

TIPRANKS
·
21 Dec 2024